The improvement in mitochondrial oxidative metabolism has been associated with resistance to the use of IDH inhibitors and the concomitant use of OxPhos inhibitors improves the efficacy of treatment against IDH mutated in vivo in AML (Stuani et al., 2021)
Supports Mitochondrial Function Mitochondrial dysfunction is a hallmark of PD
Hong JH, Hwang ES, McManus MT, et al
The findings indicate that adolescents who are prescribed glucagon-like peptide 1 receptor agonists (GLP1R) to treat obesity showed lower rates of suicidal thoughts and attempts than those prescribed lifestyle interventions, suggesting that the medication has psychiatric benefits
In current clinical practice, metformin remains the first-line pharmacologic treatment due to established evidence of its metabolic benefits, along with long-term data on safety, drug affordability, and limited trial data to support its use for reduction in MI
The results of the univariate Cox proportional hazards model showed that age and duration of diabetes were positively associated with the risk of MACES, while the use of GLP-1RA was negatively associated with the risk of MACES